APA (7th ed.) Citation

Raudanskis, A., Sarma, S., Biering-Sørensen, T., Zorcic, K., Razak, F., Verma, A., . . . Fralick, M. (2025). Identifying predictors of sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide 1 receptor agonist use in hospital among adults with diabetes. Journal of Diabetes & its Complications, 39(2), N.PAG. https://doi.org/10.1016/j.jdiacomp.2024.108945

Chicago Style (17th ed.) Citation

Raudanskis, Ashley, et al. "Identifying Predictors of Sodium-glucose Cotransporter 2 Inhibitor and Glucagon-like Peptide 1 Receptor Agonist Use in Hospital Among Adults with Diabetes." Journal of Diabetes & Its Complications 39, no. 2 (2025): N.PAG. https://doi.org/10.1016/j.jdiacomp.2024.108945.

MLA (9th ed.) Citation

Raudanskis, Ashley, et al. "Identifying Predictors of Sodium-glucose Cotransporter 2 Inhibitor and Glucagon-like Peptide 1 Receptor Agonist Use in Hospital Among Adults with Diabetes." Journal of Diabetes & Its Complications, vol. 39, no. 2, 2025, p. N.PAG, https://doi.org/10.1016/j.jdiacomp.2024.108945.